Barrett's Esophagus Cancer Risk Calculator

Estimate annual progression risk from Barrett's esophagus to esophageal adenocarcinoma. Non-dysplastic: 0.1–0.3%/year. Low-grade dysplasia: 0.5–1.0%/year. High-grade: 5–8%/year.

Weight
Height
Clinical Guidance

BMI is a screening measure of body size, not a direct measure of body fat. The standard WHO categories are underweight (<18.5), normal (18.5–24.9), overweight (25–29.9), and obese (≥30).

BMI can overestimate body fat in athletes with high muscle mass and underestimate it in older adults with low muscle mass. Interpret it alongside waist circumference and clinical context rather than as a standalone diagnosis.

⚕ Clinical Disclaimer: These calculators are for educational and reference purposes only. Always verify results with qualified clinical judgment and current clinical guidelines. Do not use as a sole basis for medical decisions.
Advertisement

How It Works

Estimate annual progression risk from Barrett's esophagus to esophageal adenocarcinoma. Non-dysplastic: 0.1–0.3%/year. Low-grade dysplasia: 0.5–1.0%/year. High-grade: 5–8%/year

Each component has a specific meaning:

  • Barrett's esophagus — The barrett's esophagus recorded for the scenario being assessed.

Note: Interpret the barrett's cancer risk result against the thresholds and context described above.

How to Use

Enter the Barrett's esophagus for the scenario you are assessing. Estimate annual progression risk from Barrett's esophagus to esophageal adenocarcinoma. Non-dysplastic: 0.1–0.3%/year. Low-grade dysplasia: 0.5–1.0%/year. High-grade: 5–8%/year. Use the barrett's cancer risk result to inform your calculation.

Related Calculators

Dukes Stage Survival

Niche Medical Tools

FIT False Positive Rate

Niche Medical Tools

MSI-H Response Rate

Niche Medical Tools

Frequently Asked Questions